Fig. 2.
Radioactive spectratype of selected CD4+ TCRBV families of IUT-treated patients. Selection was based on the most (•) and least (○) pronounced alterations during the course of IUT treatment. PCR products were analyzed on a phosphor-imager before (B) and after (A) the start of treatment.